CAD 0.4
(-1.25%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - CAD | -100.0% |
2022 | 9.4 Million CAD | 4.41% |
2021 | 9 Million CAD | 3971.9% |
2020 | 221.13 Thousand CAD | -97.37% |
2019 | 8.4 Million CAD | 188.71% |
2018 | 2.91 Million CAD | -1.18% |
2017 | 2.94 Million CAD | 2629.41% |
2016 | 107.96 Thousand CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 58.2 Thousand CAD | 0.0% |
2024 Q1 | 74.08 Thousand CAD | 0.0% |
2023 Q3 | 9.9 Million CAD | 4.85% |
2023 Q4 | - CAD | -100.0% |
2023 FY | - CAD | -100.0% |
2023 Q2 | 9.44 Million CAD | -2.26% |
2023 Q1 | 9.66 Million CAD | 2.79% |
2022 Q2 | 8.96 Million CAD | -1.25% |
2022 Q1 | 9.08 Million CAD | 0.88% |
2022 Q4 | 9.4 Million CAD | -4.12% |
2022 Q3 | 9.8 Million CAD | 9.31% |
2022 FY | 9.4 Million CAD | 4.41% |
2021 FY | 9 Million CAD | 3971.9% |
2021 Q4 | 9 Million CAD | -1.81% |
2021 Q3 | 9.17 Million CAD | -2.07% |
2021 Q2 | 9.36 Million CAD | 5238.47% |
2021 Q1 | 175.4 Thousand CAD | -20.68% |
2020 Q4 | 221.13 Thousand CAD | -13.37% |
2020 Q3 | 255.27 Thousand CAD | -66.76% |
2020 Q2 | 767.93 Thousand CAD | -91.2% |
2020 FY | 221.13 Thousand CAD | -97.37% |
2020 Q1 | 8.72 Million CAD | 3.76% |
2019 Q1 | 4.79 Million CAD | 64.76% |
2019 FY | 8.4 Million CAD | 188.71% |
2019 Q4 | 8.4 Million CAD | 0.68% |
2019 Q3 | 8.35 Million CAD | -33.76% |
2019 Q2 | 12.6 Million CAD | 162.78% |
2018 Q4 | 2.91 Million CAD | -0.94% |
2018 FY | 2.91 Million CAD | -1.18% |
2018 Q3 | 2.93 Million CAD | 0.0% |
2017 FY | 2.94 Million CAD | 2629.41% |
2017 Q4 | 2.94 Million CAD | 0.0% |
2016 FY | 107.96 Thousand CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | 100.0% |
CanadaBis Capital Inc. | 5.91 Million CAD | 100.0% |
Decibel Cannabis Company Inc. | 32.34 Million CAD | 100.0% |
Delivra Health Brands Inc. | 1.78 Million CAD | 100.0% |
Entourage Health Corp. | 5.79 Million CAD | 100.0% |
Lifeist Wellness Inc. | 868.65 Thousand CAD | 100.0% |
Cannara Biotech Inc. | 39.73 Million CAD | 100.0% |
Medicure Inc. | 229 Thousand CAD | 100.0% |
PharmaCielo Ltd. | 2.55 Million CAD | 100.0% |
BioSyent Inc. | 1.03 Million CAD | 100.0% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | 100.0% |